載入...
MEK inhibitors induce Akt activation and drug resistance by suppressing negative feedback ERK‐mediated HER2 phosphorylation at Thr701
Targeting the MEK/ERK pathway has been viewed as a promising strategy for cancer therapy. However, MEK inhibition leads to the compensatory PI3K/AKT activation and thus contributes to the desensitization of cancer cells to MEK inhibitors. The underlying molecular mechanism of this event is not yet u...
Na minha lista:
| 發表在: | Mol Oncol |
|---|---|
| Main Authors: | , , , , , , , , |
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
John Wiley and Sons Inc.
2017
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5579385/ https://ncbi.nlm.nih.gov/pubmed/28632938 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/1878-0261.12102 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|